[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100505354":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":33,"centralContacts":37,"locations":47,"responsibleParty":63,"collaborators":66,"id":86,"slug":32,"hasResults":87,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":91,"eligibilityCriteria":92,"healthyVolunteers":87,"sex":93,"minAge":94,"maxAge":32,"enrollmentInfo":95,"targetDuration":32,"studyType":98,"phases":99,"briefSummary":101,"conditions":102,"keywords":105,"overallStatus":49,"whyStopped":32,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":117},{"fullName":5,"class":6},"Peking University First Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment group","ACTIVE_COMPARATOR","Patients will be given Cholecalciferol (produced by Xymogen Company) 4000 U (2 capsules) per day",[13],"Drug: Cholecalciferol",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","PLACEBO_COMPARATOR","Patients will receive placebo, 2 capsules per day.",[19],"Drug: Placebo",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Cholecalciferol","Patients in the intervention group will receive oral cholecalciferol 4000U per day.",[9],[27],"Natural Vitamin D3",{"type":22,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"Placebo","Patients in the control group will receive placebo 2 capsules per day.",[15],null,[34],{"name":35,"affiliation":5,"role":36},"Jie Dong","PRINCIPAL_INVESTIGATOR",[38,43],{"name":39,"role":40,"phone":41,"phoneExt":32,"email":42},"Jie Dong, Professor","CONTACT","13911841538","jie.dong@bjmu.edu.cn",{"name":44,"role":40,"phone":45,"phoneExt":32,"email":46},"Zhikai Yang","13671248465","seapollar@126.com",[48],{"facility":5,"status":49,"city":50,"state":51,"zip":52,"country":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"RECRUITING","Beijing","Beijing Municipality","100034","China",{"type":55,"coordinates":56},"Point",[57,58],116.39723,39.9075,{"lat":58,"lon":57},[61],{"name":35,"role":40,"phone":62,"phoneExt":32,"email":42},"010-83572532",{"type":36,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":32,"oldOrganization":32},"Dong Jie","Director of PD center",[67,69,71,73,75,78,80,82,84],{"name":68,"class":6},"Peking University Third Hospital",{"name":70,"class":6},"Peking University People's Hospital",{"name":72,"class":6},"Beijing Haidian Hospital",{"name":74,"class":6},"Peking University Shenzhen Hospital",{"name":76,"class":77},"Beijing Fangshan District Hospital of Traditional Chinese Medicine","UNKNOWN",{"name":79,"class":6},"Peking University International Hospital",{"name":81,"class":6},"Beijing Tsinghua Changgeng Hospital",{"name":83,"class":6},"Beijing Anzhen Hospital",{"name":85,"class":6},"Capital Medical University","100505354",false,"NCT05860270","Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis","The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis, a Multicenter Randomized Controlled Trial","VD-PD","Inclusion Criteria:\n\n* Medically stable and receiving peritoneal dialysis for \\> 1 month\n* Older than 18 years old\n* Serum 25(OH)D \\\u003C 30ng\u002Fml\n* Adequate dialysis on evaluation with weekly Kt\u002FV ≥ 1.5, or (revised time: 2023-7-11) without clinical uremic symptoms\n\nExclusion Criteria:\n\n* Receive Vitamin D2\u002FD3 during the previous 1 month (revised time: 2023-7-11) ;\n* History of allergic reaction to Cholecalciferol;\n* Current or past malignant disease, active hepatitis or hepatic failure, active autoimmune disease, severe digestive malabsorption or an eating disorder, HIV\u002FAIDS;\n* Acute systemic infection, cardiovascular disease, surgery, or trauma in the last month;\n* A high probability of receiving a kidney transplant or transferring to hemodialysis or drop-out due to socioeconomic causes within 6 months;\n* History of kidney transplant;\n* Hemodialysis combined with peritoneal dialysis currently;\n* Pregnant or breastfeeding;\n* Not suitable enrolled assessed by researchers, including patients who could not regular follow-up","ALL","19 Years",{"count":96,"type":97},176,"ESTIMATED","INTERVENTIONAL",[100],"PHASE4","This is a multicenter randomized, placebo-controlled trial of Vitamin D supplementation in patients on peritoneal dialysis to determine whether oral administration of vitamin D3 after curing an episode of peritonitis could reduce the risk of subsequent peritoneal dialysis-related peritonitis.",[103,104],"Peritoneal Dialysis-associated Peritonitis","Vitamin D Deficiency",[106,107,23],"Peritoneal dialysis","Peritonitis","2024-08-05",{"date":110,"type":111},"2024-08-06","ACTUAL",{"date":113,"type":111},"2023-06-15",{"date":115,"type":97},"2026-05-31",{"name":5,"class":6},1]